JMJochen Meyburg

Jochen Meyburg

*This is an algorithmically generated author record based on publicly available information.

Jochen Meyburg has a total of 98 co-authors. Here are the top co-authors by number of shared publications:

  • Georg F. Hoffmann

    Centre for Child and Adolescent Medicine, University Hospital Heidelberg, Im Neuenheimer Feld 430, D-69120, Heidelberg, Germany

    7 shared publications
  • Jan Schmidt

    Department of Visceral and Transplant Surgery, University Hospital, Heidelberg, Germany

    5 shared publications
  • Friederike Hoerster

    Department of General Pediatrics, University Children's Hospital, Heidelberg, Germany

    3 shared publications
  • Georg Friedrich Hoffmann

    Heidelberg University, Medical Faculty Heidelberg, Heidelberg University Hospital, Center for Pediatrics and Adolescent Medicine, Department of Pediatrics I, Im Neuenheimer Feld 430, 69120 Heidelberg, Germany

    3 shared publications
  • Johann Motsch

    Department of Anesthesiology. University Hospital Heidelberg, Germany

    2 shared publications
  • Martin Lindner

    University Children's Hospital, Frankfurt am Main, Germany

    2 shared publications

Latest Publications

  • Long-Term Inhalative Sedation in Children With Pulmonary Diseases

    by Jochen Meyburg, David Frommhold, Johann Motsch, Navina Kuss

    Objectives: To describe safety and feasibility of long-term inhalative sedation (LTIS) in children with severe respiratory diseases compared to patients with normal lung function with respect to recent studies that showed beneficial effects in adult patients with acute respiratory distress syndrome (ARDS). Design: Single-center retrospective study. Setting: 12-bed pediatric intensive care unit (PICU) in a tertiary-care academic medical center in Germany. Patients: All patients treated in our PICU with LTIS using the AnaConDa® device between July 2011 and July 2019. Measurements and Main Results: Thirty-seven courses of LTIS in 29 patients were analyzed. LTIS was feasible in both groups, but concomitant intravenous sedatives could be reduced more rapidly in children with lung diseases. Cardiocirculatory depression requiring vasopressors was observed in all patients. However, severe side effects only rarely occured. Conclusions: In this largest cohort of children treated with LTIS reported so far, LTIS was feasible even in children with severely impaired lung function. From our data, a prospective trial on the use of LTIS in children with ARDS seems justified. However, a thorough monitoring of cardiocirculatory side effects is mandatory.


  • Open Access

    High blood pressure, a red flag for the neonatal manifestation of urea cycle disorders

    by Ulrike Teufel, Peter Burgard, Jochen Meyburg, Martin Lindner, Johannes Poeschl, Peter Ruef, Georg F. Hoffmann, Stefan Kölker

    Neonatal manifestation of life-threatening hyperammonemic encephalopathy in urea cycle disorders (UCD) is often misdiagnosed as neonatal sepsis, resulting in significantly delayed start of specific treatment and poor outcome. The major aim of this study was to identify specific initial symptoms or signs to clinically distinguish hyperammonemic encephalopathy in neonates from neonatal sepsis in order to identify affected individuals with UCD and to start metabolic therapy without delay. Furthermore, we evaluated the impact of diagnostic delay, peak plasma ammonium (NH4+) concentration, mode of emergency treatment and transfer to a tertiary referral center on the outcome. Detailed information of 17 patients (born between 1994 and 2012) with confirmed diagnosis of UCD and neonatal hyperammonemic encephalopathy were collected from the original medical records. The initially suspected diagnosis was neonatal sepsis in all patients, but was not confirmed in any of them. Unlike neonatal sepsis and not previously reported blood pressure increased above the 95th percentile in 13 (81%) of UCD patients before emergency treatment was started. Respiratory alkalosis was found in 11 (65%) of UCD patients, and in 14 (81%) plasma NH4+concentrations further increased despite initiation of metabolic therapy. Detection of high blood pressure could be a valuable parameter for distinguishing neonatal sepsis from neonatal manifestation of UCD. Since high blood pressure is not typical for neonatal sepsis, other reasons such as encephalopathy and especially hyperammonemic encephalopathy (caused by e.g. UCD) should be searched for immediately. However, our result that the majority of newborns with UCD initially present with high blood pressure has to be evaluated in larger patient cohorts.


  • Open Access

    Pediatric in-hospital emergencies: real life experiences, previous training and the need for training among physicians and nurses

    by Ronny Lehmann, Anke Seitz, Jochen Meyburg, Bettina Hoppe, Georg Friedrich Hoffmann, Burkhard Tönshoff, Sören Huwendiek

    Pediatric emergencies challenge professional teams by demanding substantial cognitive effort, skills and effective teamwork. Educational designs for team trainings must be aligned to the needs of participants in order to increase effectiveness. To assess these needs, a survey among physicians and nurses of a tertiary pediatric center in Germany was conducted, focusing on previous experience, previous training in emergency care, and individual training needs. Fifty-three physicians and 75 nurses participated. Most frequently experienced emergencies were respiratory failure, resuscitation, seizure, shock/sepsis and arrhythmia. Resuscitations were perceived as being particularly precarious. Team collaboration and communication were major issues arising from previous emergency situations, but perceptions differed between physicians and nurses. Regarding previous training, physicians were accustomed to self-directed learning, whereas nurses usually attended practical courses. Both physicians and nurses rated themselves as having moderate levels of knowledge and skills for pediatric emergencies, though residents reported the significantly lowest preparedness. Both professions reported a high need for training of basic procedures and emergency algorithms, physicians even more than nurses.


  • Cognitive and Behavioral Consequences of Pediatric Delirium: A Pilot Study*

    by Jochen Meyburg, Markus Ries, Matthias Zielonka, Karin Koch, Anja Sander, Rebecca von Haken, Gitta Reuner

    Objectives: To investigate the long-term impact of postoperative delirium in children. Design: Single-center point prevalence study. Setting: Twenty-two bed PICU. Patients: Forty-seven patients 1–16 years old. Interventions: Standardized neuropsychologic follow-up investigation after a mean time of 17.7 ± 2.9 months after PICU discharge. Measurements and Main Results: Pediatric delirium did not have significant long-term impact on global cognition, executive functions, or behavior. Severity of delirium did not influence the outcome. Different predictors were identified for later cognitive functioning, executive functions, and behavioral problems. Younger age was confirmed to be a relevant risk factor for delirium as well as for the cognitive and behavioral outcome. Conclusions: Contrary to the findings in adults, there was no clear association between pediatric delirium and long-term cognition or behavior in this cohort. However, this is a first pilot study with several limitations that should promote more comprehensive prospective trials.


  • Risk Factors for the Development of Postoperative Delirium in Pediatric Intensive Care Patients

    by Jochen Meyburg, Mona-Lisa Dill, Rebecca von Haken, Susanne Picardi, Jens Hendrik Westhoff, Gabrielle Silver, Chani Traube

    Objectives: To determine and quantify risk factors for postoperative pediatric delirium. Design: Single-center prospective cohort study. Setting: Twenty-two bed PICU in a tertiary care academic medical center in Germany. Patients: All children admitted after major elective surgery (n = 93; 0–17 yr). Interventions: After awakening, children were screened for delirium using the Cornell Assessment of Pediatric Delirium bid over a period of 5 days. Demographic and clinical data were collected from the initiation of general anesthesia. Measurements and Main Results: A total of 61 patients (66%) were delirious. Younger children developed delirium more frequently, and the symptoms were more pronounced. The number of preceding operations did not influence the risk of delirium. Total IV anesthesia had a lower risk than inhalational anesthesia (p < 0.05). Duration of anesthesia was similar in all groups. Patients with delirium had a longer duration of mechanical ventilation in the PICU (p < 0.001). Significant differences in cumulative doses of various medications (e.g., sedatives, analgesics, and anticholinergics) were noted between groups; these differences were independent of disease severity. Invasive catheters and respiratory devices (p < 0.01) as well as infections (p < 0.001) increased risk of delirium. Conclusions: A high prevalence of delirium was noted in the PICU, and several perioperative risk factors were identified. Our data may be a base for development of strategies to prevent and treat postoperative delirium in children.


  • Human heterologous liver cells transiently improve hyperammonemia and ureagenesis in individuals with severe urea cycle disorders

    by Jochen Meyburg, Thomas Opladen, Ute Spiekerkötter, Andrea Schlune, Jens‐Peter Schenk, Jan Schmidt, Jürgen Weitz, Jürgen Okun, Friederike Bürger, Tawfeg Ben Omran, et al.

    Background: Urea cycle disorders (UCDs) still have a poor prognosis despite several therapeutic advancements. As liver transplantation can provide a cure, liver cell therapy (LCT) might be a new therapeutic option in these patients.Methods: Twelve patients with severe UCDs were included in this prospective clinical trial. Patients received up to six infusions of cryopreserved human heterologous liver cells via a surgically placed catheter in the portal vein. Portal vein pressure, portal vein flow, and vital signs were monitored continuously. Calcineurin inhibitors and steroids were used for immunosuppression. In four patients, ureagenesis was determined with stable isotopes. Number and severity of hyperammonemic events and side effects of immunosuppression were analyzed during an observation period of up to 2 years.Results: No study‐related mortality was observed. The application catheter dislocated in two children. No significant side effects of catheter application or cell infusion were noted in the other ten patients. The overall incidence of infections did not differ significantly from a historical control group, and no specific side effects of immunosuppression were found. Seven patients were treated per protocol and could be analyzed for efficacy. Severe metabolic crises could be prevented in all of these patients, moderate crises in four of seven. Ureagenesis increased after cell infusion in all patients investigated.Conclusions: We found a favorable safety profile with respect to catheter placement, intraportal liver cell infusion, and immunosuppression. More than half of the children treated per protocol experienced metabolic stabilization and could be safely bridged to liver transplantation.


  • Erfassung eines Delirs bei pädiatrischen Intensivpatienten

    by M.-L. Dill, R. von Haken, C. Traube, G. Silver, J. Meyburg


  • In vivo monitoring of urea cycle activity with 13C-acetate as a tracer of ureagenesis

    by Thomas Opladen, Martin Lindner, Anibh M. Das, Thorsten Marquardt, Aneal Khan, Sukru H. Emre, Barbara K. Burton, Bruce A. Barshop, Thea Böhm, Jochen Meyburg, et al.


  • Disseminierte BCG-Infektion nach Stammzelltransplantation bei ‘X-Linked sever combined Immunodeficiency’ – Darstellung mittels Ganzkörper-MRT

    by A Alrajab, J Greil, J Kunz, J Meyburg, S Holland-Cunz, Jp Schenk

    Einleitung: SCID ist eine heterogene Gruppe von Immundefekterkrankungen, die vorwiegend die T-Lymphozyten betrifft und mit Störungen der B- oder NK-Zell-Immunität assoziiert ist. Es handelt sich um eine seltene Erkrankung mit einer Häufigkeit von ca. 1: 50.000–500.000 Lebendgeburten. Therapie ist Knochenmarkstransplantation und Kontrolle folgender Immunreaktionen. Klinische Angaben: Wir berichten über den Verlauf bei einem 6 Mo. alten Jungen mit SCID und BCG-Impfung sowie Stammzelltransplantation. Hierbei Meningoencephalitis sowie Haut-, Skelett-, Lungen-, abd. Organ- und LK-Befall. Methode und Ergebnis: Vor TPL Nachweis therapieresistenter vergrößerter Lymphknoten retroperitoneal sowie Milz – und Leberherde. Durch die Entwicklung einer T-Zellimmunität im Gefolge der SZT wurde eine Zunahme der Entzündungsaktivität und eine Demaskierung bislang okkulter Infektionsherde beobachtet. Mittels Ganzkörper-MRT erfolgte über 12 Monate ein Therapiemonitoring, welches neben zerebralen verkäsenden Abszedierungen auch einen retroperitonealen Abszess zeigte, der zur chirurgischen Intervention führte. Neben ZNS-Befall und LK-Befall zeigte sich ein disseminierter Skelett-, Weichteil-, und Hautbefall. Schlussfolgerung: Die GKMRT ist für ein Therapiemonitoring bei disseminierter BCG-Infektion geeignet.

  • Open Access

    Monitoring of Intraportal Liver Cell Application in Children

    by Jochen Meyburg, Friederike Hoerster, Jan Schmidt, Johannes Poeschl, Georg F. Hoffmann, Jens-Peter Schenk

    Despite recent advances and promising results in children, liver cell transplantation (LCT) should still be regarded as an experimental therapy. Several substantial complications are known from animal studies and individual patients. However, safety data on liver cell infusion in children are scarce. We used LCT in four children of different ages (3 weeks to 11 years, 3–40 kg) and underlying diseases [acute liver failure ( n = 1), urea cycle disorders ( n = 2), and Crigler-Najjar syndrome ( n = 1)]. Vital parameters, portal vein flow (PVF), portal vein pressure (PVP), and liver enzymes were measured every 5 min during cell application and hourly thereafter between applications. An application protocol with discontinuation rules depending on changes in PVF and PVP was developed and successfully applied. Application was feasible in all children despite the catastrophic overall condition of the patient with acute liver failure. No application-related changes in vital parameters were found, and none of the children experienced clinical signs of portal vein thrombosis, pulmonary embolism, or anaphylactic reactions. Time courses for changes in PVF, PVP, and liver enzymes were obtained. Thorough monitoring of portal vein pressure and duplex sonography according to a defined protocol is likely to increase safety of cell application in pediatric LCT.